Intralipid Infusions

Evidence from both animal and human studies suggest that intralipid administered intravenously may enhance implantation. Intralipid is a 20% intravenous fat emulsion used routinely as a source of fat and calories for patients requiring parental nutrition. It is composed of 10% soybean oil, 1.2% egg yolk phospholipids, 2.25% gylcerine and water. Intralipid stimulates the immune system to remove danger signals that can lead to pregnancy loss.

As the intralipid is in liquid form it is administered by inserting a cannula (a fine plastic tube) into a vein in the arm or hand.  Each infusion takes around an hour during which the patient will be seated comfortably and in private. The patient may eat and drink normally whilst the infusion is taking place and a clinical team member will monitor the patient throughout the appointment.

There are no serious adverse effects with the infusion although some patients may experience a headache, nausea or flu-like symptoms.  The infusion is not given to anyone with a known allergy to soy oil, eggs, peanut, peanut based products or any active ingredients in the infusion.  After treatment the patient can resume normal activities such as driving.